key: cord-0983095-mh0c64fp
authors: Wong, R. A.; Tan, Q. R.; Omar, U. F.; Kaliya-Perumal, A. K.
title: Uncovering career alternatives amidst the COVID-19 pandemic: a medical student’s perspective
date: 2021-09-25
journal: Public Health
DOI: 10.1016/j.puhe.2021.09.020
sha: 4fe167473f35ce7db639fceaf652c063be98781d
doc_id: 983095
cord_uid: mh0c64fp

nan

Dear Editor, Choosing a career path is arguably one of the most important decisions we must make as medical students. Upon graduation, even though there are multiple career paths to choose from, our primary focus is always on clinical specialities. While this reflects our curriculum, training and expectations, becoming a clinician-scientist, regulatory professional or healthcare policymaker are career pathways that are often overlooked. However, closely looking at the response of the biomedical fraternity to tackle this COVID-19 pandemic, it is clear that advancements in the field of medicine are only possible through key scientific discoveries that translate from bench to bedside through systematic preclinical and clinical trials subject to rigorous regulations and policy decisions. We are just starting to understand some of these, but we already see the advantage of having insights into clinical problems that could help us work on what matters most for the patients if at all we choose to proceed with such alternative career pathways.

Given the events that unfurled since the pandemic started, the multiple waves of disease transmission, and the ongoing vaccination drive, we sense a positive twist to this chapter that appeared disappointing. We are now aware of the importance of different sectors in the healthcare industry which are vital for fighting against such novel outbreaks. Scientists, clinical investigators, pharmaceutical companies, regulatory bodies, and frontline workers including doctors and paramedical staff have all had a role to play. We have not only been able to follow the whole process through media and scholarly communications, but have also directly contributed to the frontlines and community health literacy programs. These have allowed us medical students to have a better understanding of these research and pharmaceutical processes, especially the stages in vaccine development, from preclinical to clinical trials and interspersed approval checkpoints set by regulatory bodies.

We are amazed by the sped-up process with regards to the COVID-19 vaccine, with many groups of researchers and regulatory authorities working together to overlap the stages and quickly roll out a vaccine. 1 Moreover, news about our very own scientists developing novel rapid PCR tests to aid J o u r n a l P r e -p r o o f in diagnostics, 2 their ongoing work on developing therapeutics, and related regulatory bodies working in tandem to get those into the market, have sparked our interest in the field of science away from the bedside. Even though we were unexposed to these fields, we now know its pearls. We believe these are equally important fields and should continually expand for the development of newer and better solutions to healthcare problems. Of course, it will be naïve to think that we know enough to dedicate our lives to the cause immediately, but it is with no doubt that this situation has inspired many medical students to start considering these careers as alternative or adjunctive paths to clinical medicine.

This public health crisis also showed us the importance of healthcare policymaking in managing health systems. Countries that were slow to implement safe distancing, quarantine and mask-mandate suffered the worst, while the rest had flattened the curve of disease transmission quite early due to their virus-limiting policies and quick vaccination efforts. 3, 4 Furthermore, throughout this pandemic, we are aware of WHO's efforts through their media briefings and inspired by their COVID-19 vaccine initiative (COVAX) that furthered the cause of limiting COVID-19 in the less developed countries which needed vaccinations. 5 Such policy decisions make a big difference, and it highlights the need for those who know what matters most for the patients to be in such positions making policies. This opens another avenue to which we medical students could altruistically contribute to the healthcare of our society by choosing a career in public health policymaking, contributing away from the bedside but in an equally significant way.

Overall, seeing these diagnostic, therapeutic, regulatory and policymaking processes in action have enlightened us to explore more career alternatives than the customary path of aggressively pursuing clinical medicine. While the pandemic has pushed everyone to their limits mentally, emotionally and physically, with multiple distressing stories of death and doom, it has also shown medical students that healthcare is not just clinical practice, but a deep and wide field of different career avenues that contribute to benefiting the society as one healthcare fraternity. In the end, it is up to each and everyone's initiative, drive and determination to make the most out of our chosen path for the benefit of humanity in our own capacity. J o u r n a l P r e -p r o o f

COVID-19 Vaccine: A comprehensive status report

Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler

COVID-19: facts and failures, a tale of two worlds

Whose coronavirus strategy worked best? Scientists hunt most effective policies

COVID-19 vaccination: returning to WHO's Health For All